TFS is delighted to announce that János Filakovský, MD, PhD, MBA has accepted the position of CEO.
Filakovský brings a wealth of experience to TFS from the Life Science Industry, including more than 20 years serving in different leadership roles at Quintiles.
Most recently Filakovský was Regional Business Unit Head overseeing operations, legal administration, finance, business strategy and ultimately the growth of the Quintiles Clinical Operations business in Europe, Middle East and Africa and the Managing Director of the Eastern Europe Middle East Region.
Filakovský also held a seat on the European Board and the Global Executive team. Filakovský and his family will relocate from Vienna to Sweden, where he will be based at TFS headquarters in Lund.
Filakovský said: “TFS is a great company with huge potential. This is a critical time for the Life Sciences Industry and for our company. TFS has enjoyed successful growth and we have the ability to do more.”
“Rapidly evolving technology, scientific knowledge and digitalisation of clinical research processes are reshaping the Life Sciences industry. We aim to strengthen and transform TFS for tomorrow. We will help our customers develop better, safer treatments — in a faster and more efficient way.”
Jim Utterback, the previous CEO at TFS international, said: “János brings a perfect blend of science, medicine, business and operational acumen to TFS. I am very much looking forward to him joining in February to further accelerate our capabilities, service offerings and M&A strategy.”
